Skip to main content
Apply

Respiratory and Infectious Diseases

Open Main MenuClose Main Menu
  • Project/Pilot Project Leaders

    Duerfeldt, Adam, Harold Hamm Oklahoma Diabetes Center, Hit to Lead Optimization of a Novel PPAR Agonist towards a Systemically Available Treatment for Diabetic Retinopathy, 1/1/2017 – 6/30/2017, $50,000

     

    Gappa-Fahlenkamp, Heather, Oklahoma Center for Adult Stem Cell Research, Using a Tissue-Engineered Vascular Model to Develop Mast Cells from Adult Stem Cells, 07/01/16 – 06/30/17, $78,098 (Total $103,826)

     

    Gappa-Fahlenkamp, Heather, Oklahoma Center for the Advancement of Science and Technology, Ex Vivo Generation of Dendritic Cells from an Advanced Vascular Tissue Construct, 07/01/16 - 06/30/19, $135,000

     

    Kovats, Susan, and Gappa-Fahlenkamp, Heather, Oklahoma Center for Adult Stem Cell Research, Differentiation of human hematopoietic stem cells to lung resident immune cells in a tissue-engineered lung model, 01/01/17 - 12/31/18, $78,098 (Total $156,196)

     

    Lacombe, Veronique, NIH, The SERCA pump as a major regulator of glucose metabolism. 12/2016-06/2017, $50,000

     

    Lacombe, Veronique, Oklahoma Agricultural Experiment Station, USDA, Proteoglycans and insulin resistance: novel mechanisms. 12/2016-12/2017, $25,000

     

    Li, Shitao, NIH/NIAID 1R15AI126360-01A1, Taxilin alpha regulates DNA-mediated and interferon-dependent innate immunity. 02/06/2017-01/31/2020, $431,815

     

    Li, Shitao, NIH/NIAID R01AI121288, (Subcontract) Interferon-induced IFITM recruitment of ZMPSTE24 blocks viral endocytic entry, 7/1/2016 - 6/30/2020, $813,488

     

    McFarlane, Dianne, Oklahoma Agricultural Research Station, USDA. Targeted thermosensitive nanoparticle therapy for the treatment of equine endocrinopathic laminitis, 2016-2017, $25,000

     

    McFarlane, Dianne, Research Advisory Committee, Center for Veterinary Health Sciences, Oklahoma State University, Whole genome sequencing to identify genetic risk factors for pituitary pars intermedia dysfunction (PPID) and PPID-associated laminitis. 2016 - 2017, $20,000. 

     

    Miller, Kenneth, Oklahoma Center for the Advancement of Science and Technology, The role of glutamatergic sensory neurons in the initiation of and response to colitis. 08/01/16-07/31/2019, $135,000

     

    Narasaraju,Telugu, Oklahoma Center for the Advancement of Science and Technology, A novel therapy for influenza pneumonia. 09/2016 - 08/2019, $135,000    

                          

    Oomens, Antonius, NIH/NIAID 1R21AI28520-01A1, A self-limited live RSV vaccine inducing anti- pre-fusion F antibodies. 01/25/2017 - 12/31/2018, $357,172

     

    Ranjan, Ashish, Oklahoma Center for the Advancement of Science and Technology, Magnetic hyperthermia combined antimicrobial targeting of bone pathogens, 10/01/2017 – 9/30/2020, $135,000

  •  Mentors/Core Directors

    Conway,Tyrrell,  NIH R01, Mechanisms of Nutrient Competition in the Intestine, 03/01/2017-01/31/2021. $1,216,020.

     

    Eberle, Richard, NIH/OD 1R24OD022013-01, Improved treatment for zoonotic BV infections. 07/01/2016 - 03/31/2020, $1,068,582

     

    Liu, Lin, Oklahoma Center for Adult Stem Cell Research, Stem Cell-based therapy of Influenza virus Infection, 07/01/2016 - 06/30/2017, $168,00

     

    Liu, Lin, Research Advisory Committee, Center for Veterinary Health Sciences, Oklahoma State University, RNA_seq analysis of α7 nicotinic acetylcholine receptor activated lung epithelial cells, 09/2016 - 08/2017, $11,640

     

    Lloyd, Pamela, NIH/NHLBI, Regulation of placenta growth factor by hemodynamics and reactive oxygen species., 09/15/2016 - 09/31/2017, $361,738

  • Center Investigators

    Kovats, Susan, and Gappa-Fahlenkamp, Heather, Oklahoma Center for Adult Stem Cell Research, Differentiation of human hematopoietic stem cells to lung resident immune cells in a tissue-engineered lung model, 01/01/17 - 12/31/18, $78,098 (Total $156,196)

     

    Pereira, Heloise. Anne, Presbyterian Health Foundation Bridge Grant, Novel topical peptide therapeutic for the treatment of wounds infected with antibiotic resistant Gram negative bacteria, 07/01/16-06/30/17, $74,686

     

    Pereira, Heloise. Anne, NIH/NIAID 1R13AI126741-01, 49th annual meeting of the Society for Leukocyte Biology (SLB). Inflamation, immunity and cancer: neutrophils and other leukocytes. 07/15/2016 - 06/31/2017, $9,000

     

    Wang, Jun, Presbyterian Health Foundation, C5093101 Fume emission and toxicity from 3-D fabrication, 7/1/2016-6/30/2017, $49,996

     

    Xia, Lijun, NIH/NHLBI 1R01HL128390-01A1, Platelet CLES-2 regulation of vascular integrity during inflammation. 04/01/2016 - 03/31/2020, $1,715,000

     

    Xia, Lijun, NIH/NIGMS 1P30GM114731-01A1, Phenotyping core, 07/15/2016 - 04/30/2021, $2,242,500

MENUCLOSE